All Stories

  1. Delivering LINE1 antisense oligonucleotides via endothelial targeting extracellular vesicles to ameliorate myocardial infarction-induced cardiac senescence
  2. Topical application of a placental mesenchymal stem cell-embedded biomaterial hydrogel accelerates the repair of radiation-induced skin damage: a double-blind randomized phase II clinical trial
  3. The Impact of Delayed Fusion of Amnion and Chorion on Maternal and Fetal Outcomes: A Prospective Cohort Study
  4. ZFP560 facilitates KAP1-dependent chromatin repression to regulate exit from totipotency
  5. Network pharmacology and experimental verification: Rosmarinic acid alleviates doxorubicin-induced cardiomyocyte apoptosis by regulating BCL2L1
  6. Nitric oxide-primed engineered extracellular vesicles restore bioenergetics in acute kidney injury via mitochondrial transfer
  7. Extracellular vesicles derived from mesenchymal stem cells alleviate renal fibrosis via the miR-99b-5p/mTOR/autophagy axis in diabetic kidney disease
  8. Engineered extracellular vesicles promote the repair of acute kidney injury by modulating regulatory T cells and the immune microenvironment
  9. IL-1β stimulates ADAMTS9 expression and contributes to preterm prelabor rupture of membranes
  10. The Future of Healthcare: Pharmaceutical Nanotechnology
  11. Lineage Tracing Reveals that the Activation of Endogenous Sox9+ Cells Promotes Kidney Regeneration After Acute Kidney Injury
  12. Healing action of Interleukin-4 (IL-4) in acute and chronic inflammatory conditions: Mechanisms and therapeutic strategies
  13. Correction to “In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens”
  14. Engineering extracellular vesicles for targeted therapeutics in cardiovascular disease
  15. Hyaluronic acid-modified extracellular vesicles for targeted doxorubicin delivery in hepatocellular carcinoma
  16. Ligand‐Tethered Extracellular Vesicles Mediated RNA Therapy for Liver Fibrosis
  17. WITHDRAWN: Mesenchymal Stem Cells in Clinical Trials for Immune Disorders
  18. Phosphatidylserine-mediated uptake of extracellular vesicles by hepatocytes ameliorates liver ischemia-reperfusion injury
  19. Extracellular vesicles derived from mesenchymal stem cells suppress breast cancer progression by inhibiting angiogenesis
  20. Biomimetic Supramolecular Assembly with IGF‐1C Delivery Ameliorates Inflammatory Bowel Disease (IBD) by Restoring Intestinal Barrier Integrity
  21. Therapeutic trends of priming mesenchymal stem cells: A bibliometric analysis
  22. iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review
  23. Combined lineage tracing and scRNA‐seq reveal the activation of Sox9+ cells in renal regeneration with PGE2 treatment
  24. Extracellular vesicles: A new frontier in the theranostics of cardiovascular diseases
  25. In vivo tracking of mesenchymal stem cell dynamics and therapeutics in LPS-induced acute lung injury models
  26. Biomaterials and Mesenchymal Stem Cells
  27. Pioneering the Future of Medicine: Exploring the Frontiers of Pharmaceutical Nanotechnology
  28. PAFAH2 suppresses synchronized ferroptosis to ameliorate acute kidney injury
  29. Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases
  30. Mesenchymal Stem Cells in Clinical Trials for Immune Disorders
  31. Extracellular Vesicle: Biology and Translational Application
  32. Extracellular Vesicles in Pregnancy: Functional Insights, Diagnostic Potential for Maternal–Fetal Disorders, and Therapeutic Implications
  33. Extracellular Vesicles: Tiny Packages with Big Potential
  34. Mesenchymal stem cell-derived extracellular vesicles targeting irradiated intestine exert therapeutic effects
  35. Regulation and Mechanisms of Exosome Cargo Selection and Secretion
  36. Technologies for EV Surface Modification and its Application in Targeted Therapy
  37. The Significance of Biomaterials in Stem Cell-Based Regenerative Medicine
  38. Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
  39. Embryonic stem cell-derived extracellular vesicles rejuvenate senescent cells and antagonize aging in mice
  40. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
  41. Subconjunctival Administration of Mesenchymal Stem Cells Alleviates Ocular Inflammation in a Murine Model of Corneal Alkali Burn
  42. Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage immunomodulation
  43. Mesenchymal stem cells: A promising weapon for cancer therapy
  44. The enhanced therapeutic potential of MSC with biomaterials application
  45. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
  46. Off-the-shelf GMP-grade UC-MSCs as therapeutic drugs for the amelioration of CCl4-induced acute-on-chronic liver failure in NOD-SCID mice
  47. Enhancement of hair growth through stimulation of hair follicle stem cells by prostaglandin E2 collagen matrix
  48. The RGD-modified self-assembling D-form peptide hydrogel enhances the therapeutic effects of mesenchymal stem cells (MSC) for hindlimb ischemia by promoting angiogenesis
  49. Heparan sulfate proteoglycan-mediated internalization of extracellular vesicles ameliorates liver fibrosis by targeting hepatic stellate cells
  50. Renal Endothelial Cell‐Targeted Extracellular Vesicles Protect the Kidney from Ischemic Injury
  51. Advances and Perspectives of Pharmaceutical Nanotechnology in mRNA therapy
  52. Biosynthetic Dendritic Cell-Exocytosed Aggregation-Induced Emission Nanoparticles for Synergistic Photodynamic Immunotherapy
  53. Changes in serum angiogenic factors among patients with acute pain and subacute pain
  54. Therapeutic application of tumour cell‐derived extracellular vesicles for drug‐resistant cancer therapy via interleukin 6/signal transducer and activator of transcription 3 signalling pathway
  55. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection
  56. Maternal Factor Dppa3 Activates 2C-Like Genes and Depresses DNA Methylation in Mouse Embryonic Stem Cells
  57. Nitric oxide improves regeneration and prevents calcification in bio-hybrid vascular grafts via regulation of vascular stem/progenitor cells
  58. A supramolecular hydrogel based on the combination of YIGSR and RGD enhances mesenchymal stem cells paracrine function via integrin α2β1 and PI3K/AKT signaling pathway for acute kidney injury therapy
  59. Dppa3 facilitates self-renewal of embryonic stem cells by stabilization of pluripotent factors
  60. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia
  61. Comparison of the treatment efficacy of umbilical mesenchymal stem cell transplantation via renal subcapsular and parenchymal routes in AKI-CKD mice
  62. The sustained PGE2 release matrix improves neovascularization and skeletal muscle regeneration in a hindlimb ischemia model
  63. Editorial
  64. Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9+ renal tubular cells
  65. Constructing a cell microenvironment with biomaterial scaffolds for stem cell therapy
  66. High TSPAN8 expression in epithelial cancer cell‐derived small extracellular vesicles promote confined diffusion and pronounced uptake
  67. Renal subcapsular delivery of PGE2 promotes kidney repair by activating endogenous Sox9+ stem cells
  68. Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Radiation-Induced Lung Injury via miRNA-214-3p
  69. Extracellular vesicles derived from mesenchymal stem cells as a potential therapeutic agent in acute kidney injury (AKI) in felines: review and perspectives
  70. Platelet extracellular vesicles enhance the proangiogenic potential of adipose-derived stem cells in vivo and in vitro
  71. Embryonic stem cell-derived extracellular vesicles promote the recovery of kidney injury
  72. Meet the Editor-in-Chief
  73. Intravital microscopy imaging of kidney injury and regeneration
  74. CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis
  75. Chitosan hydrogel-loaded MSC-derived extracellular vesicles promote skin rejuvenation by ameliorating the senescence of dermal fibroblasts
  76. Sulfated glycosaminoglycans in decellularized placenta matrix as critical regulators for cutaneous wound healing
  77. Isolation and Multiple Differentiation of Rat Pericardial Fluid Cells
  78. Intranasal delivery of MSC-derived exosomes attenuates allergic asthma via expanding IL-10 producing lung interstitial macrophages in mice
  79. Multifaceted Optimization of MSC-Based Formulation upon Sodium Iodoacetate-Induced Osteoarthritis Models by Combining Advantageous HA/PG Hydrogel and Fluorescent Tracer
  80. The delivery of hsa-miR-11401 by extracellular vesicles can relieve doxorubicin-induced mesenchymal stem cell apoptosis
  81. Two-step generation of mesenchymal stem/stromal cells from human pluripotent stem cells with reinforced efficacy upon osteoarthritis rabbits by HA hydrogel
  82. Role of prostaglandin E2 in tissue repair and regeneration
  83. Applications of Decellularized Extracellular Matrix for Regenerative Medicine
  84. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer
  85. Chitosan Hydrogel-loaded MSC-derived Extracellular Vesicles Promote Skin Rejuvenation by Ameliorating the Senescence of Dermal Fibroblasts
  86. <p>Celecoxib Exerts a Therapeutic Effect Against Demyelination by Improving the Immune and Inflammatory Microenvironments</p>
  87. Spatio-Temporal Metabolokinetics and Efficacy of Human Placenta-Derived Mesenchymal Stem/Stromal Cells on Mice with Refractory Crohn’s-like Enterocutaneous Fistula
  88. A nitric oxide-releasing hydrogel for enhancing the therapeutic effects of mesenchymal stem cell therapy for hindlimb ischemia
  89. Supramolecular Nanofibers Containing Arginine-Glycine-Aspartate (RGD) Peptides Boost Therapeutic Efficacy of Extracellular Vesicles in Kidney Repair
  90. In vivo two-photon microscopy reveals the contribution of Sox9+ cell to kidney regeneration in a mouse model with extracellular vesicle treatment
  91. Abstract 328: Enhanced Therapeutic Effects of Mesenchymal Stem Cells for Hindlimb Ischemia by a Nitric Oxide Hydrogel Through Mesenchymal-endothelial Transition
  92. Extracellular vesicles derived from human placental mesenchymal stem cells alleviate experimental colitis in�mice by inhibiting inflammation and oxidative stress
  93. IGF-1C domain-modified chitosan hydrogel accelerates cutaneous wound healing by promoting angiogenesis
  94. <p>Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy</p>
  95. Correction to: IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  96. Enhanced therapeutic effects of MSC-derived extracellular vesicles with an injectable collagen matrix for experimental acute kidney injury treatment
  97. In Vivo Tracking of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improving Mitochondrial Function in Renal Ischemia–Reperfusion Injury
  98. IGF-1C domain–modified hydrogel enhanced the efficacy of stem cells in the treatment of AMI
  99. Human Supernumerary Teeth-Derived Apical Papillary Stem Cells Possess Preferable Characteristics and Efficacy on Hepatic Fibrosis in Mice
  100. IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization
  101. Mesenchymal Stem Cell-Derived Extracellular Vesicles for Corneal Wound Repair
  102. The Application of Methylprednisolone Nanoscale Zirconium-Porphyrin Metal-Organic Framework (MPS-NPMOF) in the Treatment of Photoreceptor Degeneration
  103. Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease
  104. Nitric‐Oxide‐Releasing Biomaterial Regulation of the Stem Cell Microenvironment in Regenerative Medicine
  105. Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
  106. The role of biomaterials in stem cell-based regenerative medicine
  107. JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia
  108. MSC-derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia
  109. IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia
  110. In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens
  111. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model
  112. Molecular Imaging of Therapeutic Effect of Mesenchymal Stem Cell-Derived Exosomes for Hindlimb Ischemia Treatment
  113. Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
  114. Introduction of Perinatal Tissue-Derived Stem Cells
  115. Perinatal Stem Cells in Kidney Regeneration: Current Knowledge and Perspectives
  116. Proangiogenic Features of Perinatal Tissue-Derived Stem Cells in Cardiovascular Disease Therapy
  117. Perinatal Stem Cells
  118. Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma
  119. Dppa3 is critical for Lin28a-regulated ES cells naïve–primed state conversion
  120. Dppa3 in pluripotency maintenance of ES cells and early embryogenesis
  121. MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway
  122. Stat3 activation is critical for pluripotency maintenance
  123. Enhanced Therapeutic Effects of Mesenchymal Stem Cell-Derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment
  124. Abstract 490: Enhanced Therapeutic Effects of MSC-derived Exosomes with an Injectable Hydrogel for Hindlimb Ischemia Treatment
  125. Directed Differentiation of Human Corneal Endothelial Cells From Human Embryonic Stem Cells by Using Cell-Conditioned Culture Media
  126. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction
  127. Current View on Hematopoiesis and Beyond
  128. Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging
  129. VE-Cadherin regulates the self-renewal of mouse embryonic stem cells via LIF/Stat3 signaling pathway
  130. Knockout of zebrafish interleukin 7 receptor (IL7R) by the CRISPR/Cas9 system delays retinal neurodevelopment
  131. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway
  132. Inflammatory Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Stem Cell-Like Characteristics of Cancer Cells in an IL-1β-Dependent Manner
  133. Hydrogel-Based Strategies for Stem Cell Therapy
  134. Prostaglandin E2 hydrogel improves cutaneous wound healing via M2 macrophages polarization
  135. Nitric oxide releasing hydrogel promotes endothelial differentiation of mouse embryonic stem cells
  136. A macroporous heparin-releasing silk fibroin scaffold improves islet transplantation outcome by promoting islet revascularisation and survival
  137. Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence
  138. Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer
  139. Down-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination
  140. Stat3 phosphorylation is required for embryonic stem cells ground state maintenance in 2i culture media
  141. Three structurally related Copper complexes with two isomers: DNA/BSA binding ability, DNA cleavage activity and excellent cytotoxicity
  142. Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats
  143. Molecular Imaging of Inducible VEGF Expression and Tumor Progression in a Breast Cancer Model
  144. LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling
  145. Meet Our Editorial Board Member
  146. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta
  147. Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction
  148. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer
  149. Interferon-γ alters the microRNA profile of umbilical cord-derived mesenchymal stem cells
  150. Erratum: Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  151. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer
  152. Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells
  153. Bone Marrow Mesenchymal Stem Cells (BM-MSCs) Improve Heart Function in Swine Myocardial Infarction Model through Paracrine Effects
  154. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis
  155. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity
  156. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects
  157. IGF-1 C Domain–Modified Hydrogel Enhances Cell Therapy for AKI
  158. Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
  159. Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications
  160. Controlled nitric oxide release for tissue repair and regeneration
  161. Translational applications of molecular imaging in cardiovascular disease and stem cell therapy
  162. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
  163. Extracellular Matrix can Recover the Downregulation of Adhesion Molecules after Cell Detachment and Enhance Endothelial Cell Engraftment
  164. Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells
  165. Activating Transcription Factor 4 Promotes Angiogenesis of Breast Cancer through Enhanced Macrophage Recruitment
  166. Angiogenesis
  167. Molecular Imaging: The Key to Advancing Stem Cell Therapy
  168. OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction
  169. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells
  170. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle
  171. Phase dependent luminescent property of N,N-di(n-octyl)quinacridone crystals
  172. Traceable Therapeutic Strategy for Treatment of Breast Cancer with Mesenchymal Stem Cells (MSCs)
  173. IFN-γ mediates graft-versus-breast cancer effects via enhancing cytotoxic T lymphocyte activity
  174. Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy
  175. Synthesis, Biodistribution, and Imaging of PEGylated-Acetylated Polyamidoamine Dendrimers
  176. Tumor necrosis factor-α regulates matrix metalloproteinase-2 expression and cell migration via ERK pathway in rat glomerular mesangial cells
  177. Bone Marrow Vascular Niche: Home for Hematopoietic Stem Cells
  178. Nanoparticle-Based Tumor Theranostics with Molecular Imaging
  179. The role of Hath6, a newly identified shear-stress-responsive transcription factor, in endothelial cell differentiation and function
  180. Human Embryonic Stem Cell-Derived Endothelial Cells as Cellular Delivery Vehicles for Treatment of Metastatic Breast Cancer
  181. Noninvasive Imaging of Hypoxia-Inducible Factor-1α Gene Therapy for Myocardial Ischemia
  182. Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53
  183. Human embryonic stem cells-derived endothelial cell therapy facilitates kidney regeneration by stimulating renal resident stem cell proliferation in acute kidney injury
  184. Imaging Neural Stem Cell Graft-Induced Structural Repair in Stroke
  185. The Phenotypic Fate of Bone Marrow-Derived Stem Cells in Acute Kidney Injury
  186. Bioluminescence Imaging of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  187. Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction
  188. Assessment of Therapeutic Efficacy of Liposomal Nanoparticles Mediated Gene Delivery by Molecular Imaging for Cancer Therapy
  189. Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury
  190. Improved mesenchymal stem cell survival in ischemic heart through electroacupuncture
  191. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
  192. Legumain: A biomarker for diagnosis and prognosis of human ovarian cancer
  193. Fra-1 Promotes Breast Cancer Chemosensitivity by Driving Cancer Stem Cells from Dormancy
  194. Activating transcription factor 4 increases chemotherapeutics resistance of human hepatocellular carcinoma
  195. Abstract 415: Human embryonic stem cell-derived endothelial cells as cellular delivery vehicles for targeting therapy of metastatic breast cancer
  196. Exosomes for Ophthalmic Therapeutics
  197. Functional Characterization and Expression Profiling of Human Induced Pluripotent Stem Cell- and Embryonic Stem Cell-Derived Endothelial Cells
  198. Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation
  199. Preparation and Evaluation of Magnetic Nanoparticles for Cell Labeling
  200. Abstract 2464: Targeting liver cancer stem cells for molecular imaging and therapeutic application
  201. Bioluminescence reporter gene imaging characterize human embryonic stem cell-derived teratoma formation
  202. Effects of Long-Term Culture on Human Embryonic Stem Cell Aging
  203. MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
  204. Effects of Ionizing Radiation on Self-Renewal and Pluripotency of Human Embryonic Stem Cells
  205. Embryonic Stem Cell–Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion
  206. Human Neural Stem Cell Grafts Modify Microglial Response and Enhance Axonal Sprouting in Neonatal Hypoxic–Ischemic Brain Injury
  207. A nonviral minicircle vector for deriving human iPS cells
  208. Functional and Transcriptional Characterization of Human Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Myocardial Infarction
  209. nAChRs Mediate Human Embryonic Stem Cell-Derived Endothelial Cells: Proliferation, Apoptosis, and Angiogenesis
  210. Novel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
  211. Molecular and Magnetic Resonance Imaging of Human Embryonic Stem Cell–Derived Neural Stem Cell Grafts in Ischemic Rat Brain
  212. Imaging Survival and Function of Transplanted Cardiac Resident Stem Cells
  213. Imaging of STAT3 Signaling Pathway During Mouse Embryonic Stem Cell Differentiation
  214. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases
  215. Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
  216. Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality
  217. Comparison of Reporter Gene and Iron Particle Labeling for Tracking Fate of Human Embryonic Stem Cells and Differentiated Endothelial Cells in Living Subjects
  218. Genetic Modification of Embryonic Stem Cells with VEGF Enhances Cell Survival and Improves Cardiac Function
  219. Differentiation, Survival, and Function of Embryonic Stem Cell Derived Endothelial Cells for Ischemic Heart Disease
  220. Positron emission tomography imaging of conditional gene activation in the heart
  221. Molecular Imaging of Embryonic Stem Cell Misbehavior and Suicide Gene Ablation
  222. Quantum dot imaging for embryonic stem cells
  223. Anti-angiogenesis effects of meisoindigo on chronic myelogenous leukemia in vitro
  224. Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation
  225. Enhancement of neovascularization with cord blood CD133 + cells-derived endothelial progenitor cells transplantation